Cardiovascular Systems Stock Price To Earnings To Growth
| CSIIDelisted Stock | USD 20.00 0.00 0.00% |
Cardiovascular Systems fundamentals help investors to digest information that contributes to Cardiovascular Systems' financial success or failures. It also enables traders to predict the movement of Cardiovascular Stock. The fundamental analysis module provides a way to measure Cardiovascular Systems' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cardiovascular Systems stock.
Cardiovascular |
Cardiovascular Systems Company Price To Earnings To Growth Analysis
Cardiovascular Systems' PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Current Cardiovascular Systems Price To Earnings To Growth | 177.27 X |
Most of Cardiovascular Systems' fundamental indicators, such as Price To Earnings To Growth, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cardiovascular Systems is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
CompetitionBased on the latest financial disclosure, Cardiovascular Systems has a Price To Earnings To Growth of 177 times. This is much higher than that of the Health Care Equipment & Supplies sector and notably higher than that of the Health Care industry. The price to earnings to growth for all United States stocks is notably lower than that of the firm.
Cardiovascular Price To Earnings To Growth Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cardiovascular Systems' direct or indirect competition against its Price To Earnings To Growth to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Cardiovascular Systems could also be used in its relative valuation, which is a method of valuing Cardiovascular Systems by comparing valuation metrics of similar companies.Cardiovascular Systems is currently under evaluation in price to earnings to growth category among its peers.
Cardiovascular Fundamentals
| Return On Equity | -0.15 | |||
| Return On Asset | -0.0756 | |||
| Profit Margin | (0.16) % | |||
| Operating Margin | (0.16) % | |||
| Current Valuation | 466.13 M | |||
| Shares Outstanding | 42.2 M | |||
| Shares Owned By Insiders | 3.22 % | |||
| Shares Owned By Institutions | 89.64 % | |||
| Number Of Shares Shorted | 1.74 M | |||
| Price To Earning | 724.24 X | |||
| Price To Book | 2.43 X | |||
| Price To Sales | 2.51 X | |||
| Revenue | 236.22 M | |||
| Gross Profit | 172.78 M | |||
| EBITDA | (29.96 M) | |||
| Net Income | (36.93 M) | |||
| Cash And Equivalents | 159.83 M | |||
| Cash Per Share | 3.90 X | |||
| Total Debt | 22.15 M | |||
| Debt To Equity | 0.09 % | |||
| Current Ratio | 6.05 X | |||
| Book Value Per Share | 5.70 X | |||
| Cash Flow From Operations | (24.27 M) | |||
| Short Ratio | 2.66 X | |||
| Earnings Per Share | (0.96) X | |||
| Price To Earnings To Growth | 177.27 X | |||
| Target Price | 16.75 | |||
| Number Of Employees | 725 | |||
| Beta | 0.74 | |||
| Market Capitalization | 843.96 M | |||
| Total Asset | 322.68 M | |||
| Retained Earnings | (320 M) | |||
| Working Capital | 69.38 M | |||
| Current Asset | 104.88 M | |||
| Current Liabilities | 35.5 M | |||
| Z Score | 22.8 | |||
| Net Asset | 322.68 M |
About Cardiovascular Systems Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cardiovascular Systems's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cardiovascular Systems using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cardiovascular Systems based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Consideration for investing in Cardiovascular Stock
If you are still planning to invest in Cardiovascular Systems check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cardiovascular Systems' history and understand the potential risks before investing.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |